About
Tevard develops novel tRNA-based gene therapies to treat and potentially cure rare genetic diseases caused by nonsense mutations, including Duchenne muscular dystrophy and dilated cardiomyopathy.
Explore Tevard's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.